Wellbutrin
Bipolar II Disorder
Mayo ClinicPhase 4 / ApprovedActive
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 81/ 100
Competitive context
17 Active assets in the Bipolar II Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Seroquel® First Affiliated Hospital of Zhejiang University | Phase 4 | BB |
Bxcl501 BioXcel Therapeutics Inc | Phase 3 | BB |
ZIPRASIDONE The Medical Research Network | Phase 4 | B |
Naltrexone Mayo Clinic | Phase 4 | B |
Semaglutide Mayo Clinic | Phase 4 | B |
View all 17 →
Same molecule, other indications
Wellbutrin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →